Active Power (ACPW)

Create an Alert
4.28 +0.02  +0.47%   NASDAQ Jun 19, 8:00PM BATS Real time Currency in USD

Active Power R&D Expense Quarterly:

1.631M for March 31, 2013
View Full Chart

Active Power R&D Expense Quarterly Chart

    Active Power Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 1.631M
    Dec. 31, 2012 1.395M
    Sept. 30, 2012 1.325M
    June 30, 2012 1.432M
    March 31, 2012 1.288M
    Dec. 31, 2011 1.46M
    Sept. 30, 2011 1.272M
    June 30, 2011 1.086M
    March 31, 2011 0.921M
    Dec. 31, 2010 0.895M
    Sept. 30, 2010 0.833M
    June 30, 2010 0.849M
    March 31, 2010 0.835M
    Dec. 31, 2009 0.916M
    Sept. 30, 2009 1.095M
    June 30, 2009 1.058M
    March 31, 2009 1.101M
    Dec. 31, 2008 1.213M
    Sept. 30, 2008 1.197M
    June 30, 2008 1.304M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    ACPW R&D Expense Quarterly Benchmarks

    Companies
    Actuant
    Briggs & Stratton Corporation
    Hydrogenics Corporation 0.938M

    ACPW R&D Expense Quarterly Rankings

    Overall 91st percentile
    1429 of 16782
    Sector 93rd percentile
    152 of 2441 in Industrials
    Industry 79th percentile
    60 of 296 in Diversified Industrials

    ACPW R&D Expense Quarterly Range, Past 5 Years

    Minimum 0.8330M Sep 2010
    Maximum 1.631M Mar 2013
    Average 1.155M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');